Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Clinical trial NCT03422094 · TERMINATED
Trial details
- NCT number
- NCT03422094
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2020-04-26
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.